A	B	C
1	Main
2		Brand Name	Byetta LAR
3		Generic Name	exenatide
4		Dosage	qw versus bid
5		Economics	7.5% royalty from AMLN/LLY.
6		Clinical Trials
7			Phase III DURATION-3 head-to-head versus Lantus
8			1.5% A1C reduction versus 1.3% for Lantus
9			5.8lbs weight loss at 26 weeks versus 3.1lbs weight gain for Lantus.
10
11			Phase III DURATION-4
12
13			Phase III DURATION-5 - head-to-head versus Byetta
14
15			Phase III DURATION-6 - head-to-head versus liraglutide